Brief: Innovent Biologics Announces Entering Into Exclusive Global License Agreement
02/01/2025 24:57
Jan 2 (Reuters) - Innovent Biologics Inc 1801.HK :
* ENTERING INTO EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH
ROCHE FOR
NOVEL DLL3 ADC
* UNITS & F. HOFFMANN-LA ROCHE, HOFFMANN-LA ROCHE ENTERED
INTO
COLLABORATION & EXCLUSIVE LICENSE AGREEMENT
Further company coverage: 1801.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innovent Biologics
See all newsChina emerges as obesity drug lab for Big Pharma
Eli Lilly becomes first drugmaker to have a GLP-1 weight-loss pill approved in China (updated)
China emerges as obesity drug lab for Big Pharma
Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive third-quarter results (updated)
Refile: Pfizer raises 2026 forecast on strong demand for blood thinner Eliquis